0001209191-17-005349.txt : 20170124
0001209191-17-005349.hdr.sgml : 20170124
20170124175220
ACCESSION NUMBER: 0001209191-17-005349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170120
FILED AS OF DATE: 20170124
DATE AS OF CHANGE: 20170124
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaye Edward M. MD
CENTRAL INDEX KEY: 0001522780
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 17544654
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
CITY: BOTHELL
STATE: WA
ZIP: 98011
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-01-20
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001522780
Kaye Edward M. MD
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
1
1
0
0
President, CEO & CMO
Common Stock
2017-01-20
4
F
0
4466
32.66
D
71169
D
Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.
/s/David Tyronne Howton, as Attorney-in-Fact for Edward M. Kaye
2017-01-24